JAMPJ HID RISPERDAL STUDIES TO BOOST DRUG SALES LAWYER SAYS
February 3, 2012
Johnson & Johnson hid studies showing its Risperdal anti-psychotic drug caused diabetes to protect billions of dollars in sales, a lawyer said in the first personal-injury claim over the medication to go to trial.
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from National News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
